Chronic lymphocytic leukemia (CLL)-derived EVs were shown to down-regulate CD69 expression in T-cells via miR-363 transfer, thereby affecting effector T-cell migration [109,110,111]. The gene discussed is CD69; the disease is B-cell chronic lymphocytic leukemia.